Literature DB >> 1702293

Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein.

A Himmler1, I Maurer-Fogy, M Krönke, P Scheurich, K Pfizenmaier, M Lantz, I Olsson, R Hauptmann, C Stratowa, G R Adolf.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha), a protein released by activated macrophages, is involved in a wide variety of human diseases including septic shock, cachexia, and chronic inflammation. TNF binding protein (TNF-BP), a glycoprotein with high affinity to TNF-alpha isolated from urine, acts as an inhibitor of TNF-alpha by competing with the cell-surface TNF receptor. We report here the partial amino acid sequencing of human TNF-BP as well as the isolation, sequence, and expression of cDNA clones encoding a human and rat TNF receptor. The calculated Mr of the mature human and rat TNF receptor chains is 47,526 and 48,072, respectively. The extracellular ligand binding domain represents the soluble TNF-BP which is released by proteolytic cleavage. TNF-BP contains 24 cysteine residues and three potential N-glycosylation sites and shows sequence homology to the extracellular portions of TNF-R p80 chain and nerve growth factor receptor. Transfection of the human TNF receptor cDNA into mammalian cells resulted in increased binding capacity for TNF-alpha and increased reactivity with a monoclonal antibody directed against the human TNF receptor chain p60. When a stop codon was introduced into the cDNA at the site corresponding to the carboxyl terminus of TNF-BP, transfected cells secreted a protein that reacted with antibodies raised against natural TNF-BP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702293     DOI: 10.1089/dna.1990.9.705

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  21 in total

1.  Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene.

Authors:  Xiaobing Zhou; Lianzhong Shen; Li Liu; Chao Wang; Weihong Qi; Aizhi Zhao; Xiaobing Wu; Bo Li
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Tumor necrosis factor alpha activates the phosphorylation of ERK, SAPK/JNK, and P38 kinase in primary cultures of neurons.

Authors:  G Barbin; M P Roisin; B Zalc
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

3.  The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi.

Authors:  C Truyens; F Torrico; R Lucas; P De Baetselier; W A Buurman; Y Carlier
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 4.  Soluble receptors for cytokines and growth factors: generation and biological function.

Authors:  S Rose-John; P C Heinrich
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

5.  Shedding of TNFR1 in regenerative liver can be induced with TNF alpha and PMA.

Authors:  Min Xia; Shao-Bai Xue; Cun-Shuan Xu
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

6.  Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection.

Authors:  Qiong-Ying Hu; Elizabeth Fink; John H Elder
Journal:  Retrovirology (Auckl)       Date:  2012-07-11

7.  Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I.

Authors:  C L Selinsky; K L Boroughs; W A Halsey; M D Howell
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

Review 8.  Tumor necrosis factor receptors--structure and function.

Authors:  J Rothe; G Gehr; H Loetscher; W Lesslauer
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

9.  Analysis of p60 and p80 tumor necrosis factor-alpha receptor messenger RNA and protein in human placentas.

Authors:  K K Yelavarthi; J S Hunt
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

10.  On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.

Authors:  M Lantz; H Thysell; E Nilsson; I Olsson
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.